StopDown
Zenex Animal Health logo
Acquisition · 30 September 2026Zenex Animal HealthAnimal health makerzenexah.com ↗

Zenex buys SAVAVET pet care business

By · Editor ·

Ahmedabad
  • Zenex makes veterinary medicines for livestock, poultry and pets, and is backed by private equity investor Multiples
  • It has bought SAVAVET, the companion animal unit of SAVA Healthcare, on an undisclosed price
  • SAVAVET sells about 70 brands through 165 stockists and more than 6,000 vets, making this Zenex's third buyout under Multiples

What happened

  • Zenex has bought SAVAVET, the pet care arm of SAVA Healthcare.
  • The price was not disclosed.
  • It is Zenex's third acquisition since Multiples invested.
  • Earlier deals were Ayurvet and VievePharma.
  • SAVAVET sells about 70 brands.

Why it matters

  • Pet healthcare is one of the fastest-growing parts of India's animal health market.
  • The deal gives Zenex established brands and vet ties.
  • SAVA Healthcare can focus on human health.

The business

  • Zenex makes and sells animal medicines and feed supplements for livestock, poultry and pets.
  • Its range covers antibiotics, vitamin injections, hormones, udder-infection treatments, poultry vaccines and growth promoters.
  • It makes products at its Haridwar plant and sells to farmers and vets through a field team of 1,200+ sales staff.
  • It earns by selling these products in India and in 15+ export countries across the Middle East, Africa, Eastern Europe and Southeast Asia.
  • Revenue was about ₹1,023 crore in FY 2025, up 24% on the year before.
  • In 2026 it bought a majority of a Dutch animal nutrition firm, widening its reach abroad.

Who put in money

In numbers

₹1,023 CrRevenue · FY2025
1,200+Sales staff · 2026
15+Export countries · 2026
1,626Employees · 2025

Earlier rounds

  • Dec 2021: IFC and Emerging Asia Fund proposed to buy up to $52.5 million of shares from Multiples PE Fund III (about $16 million IFC, $36.5 million EAF)
  • Multiples PE, with other investors, backs the company after it was formed by buying Zydus Animal Health and Investment, a former Cadila Healthcare unit

Up against

Boehringer IngelheimElancoZoetisAlltechBayer

The numbers around it

Zenex Animal Health has 1 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
6 December 2021Growth equity$52.5 millionUndefined

Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →

Read it as a card in the app

Terms in this story

  • Private equity: Venture capital backs young companies that could grow very fast, taking small stakes and accepting that many will fail, while private equity backs mature companies, often with large or controlling stakes and steadier returns. In India both usually invest through SEBI-registered AIFs, with venture capital funds in Category I and most private equity in Category II.
  • Strategic vs financial sale: A strategic sale is when a startup is sold to another operating company that wants its product, customers or team. A financial sale is when it is sold to an investor, usually a private equity fund, that wants a return on the money it puts in. The buyer type changes the price, the terms and what happens to founders and staff afterwards.

Everything on Zenex Animal Health → · All startup news on 30 September 2026 →

Is this Zenex Animal Health? Get your “Featured on StopDown” badge →